[Market Focus] Curiosis Hits Upper Price Limit on First Trading Day... Quadruples IPO Price

Curiosis surged to the upper price limit immediately upon opening on its first day of trading on the KOSDAQ.

As of 10:10 a.m. on November 13, Curiosis shares were trading at 88,000 won, up 300.0%, the maximum daily increase, compared to the initial public offering price. This is four times higher than the IPO price of 22,000 won.

Curiosis is a company specializing in laboratory automation equipment. Based on its proprietary "CurioSystem" platform, which incorporates core source technologies essential for laboratory automation systems, the company has launched products such as the automated cell imaging system Celloger and Cellfury. Curiosis has built a product portfolio that can be immediately supplied to large and high-growth markets, including synthetic biology, digital pathology, cell separation, live cell imaging, and automation for cell therapy applications.

During the public subscription held for institutional and retail investors on November 4 and 5, Curiosis recorded a subscription competition ratio of 2,203.97 to 1. The deposit for the subscription reached approximately 7.27 trillion won. Previously, in the book-building process for institutional investors, the IPO price was set at the upper end of the desired price band (18,000 to 22,000 won), at 22,000 won.

This content was produced with the assistance of AI translation services.